299 related articles for article (PubMed ID: 19789328)
41. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity.
Wang KS; Ma J; Mi C; Li J; Lee JJ; Jin X
Oncol Rep; 2016 Apr; 35(4):2045-52. PubMed ID: 26781327
[TBL] [Abstract][Full Text] [Related]
42. Chrysin inhibits expression of hypoxia-inducible factor-1alpha through reducing hypoxia-inducible factor-1alpha stability and inhibiting its protein synthesis.
Fu B; Xue J; Li Z; Shi X; Jiang BH; Fang J
Mol Cancer Ther; 2007 Jan; 6(1):220-6. PubMed ID: 17237281
[TBL] [Abstract][Full Text] [Related]
43. Hypoxia induces the dysfunction of human endothelial colony-forming cells via HIF-1α signaling.
He M; Ma S; Cai Q; Wu Y; Shao C; Kong H; Wang H; Zeng X; Xie W
Respir Physiol Neurobiol; 2018 Jan; 247():87-95. PubMed ID: 28964937
[TBL] [Abstract][Full Text] [Related]
44. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
[TBL] [Abstract][Full Text] [Related]
45. Montelukast inhibits hypoxia inducible factor-1α translation in prostate cancer cells.
Tang C; Lei H; Zhang J; Liu M; Jin J; Luo H; Xu H; Wu Y
Cancer Biol Ther; 2018 Aug; 19(8):715-721. PubMed ID: 29708817
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and evaluation of biarylquinoline derivatives as novel HIF-1α inhibitors.
Wu YC; Lu MT; Lin TH; Chu PC; Chang CS
Bioorg Chem; 2022 Apr; 121():105681. PubMed ID: 35176558
[TBL] [Abstract][Full Text] [Related]
47. Salternamide A Suppresses Hypoxia-Induced Accumulation of HIF-1α and Induces Apoptosis in Human Colorectal Cancer Cells.
Bach DH; Kim SH; Hong JY; Park HJ; Oh DC; Lee SK
Mar Drugs; 2015 Nov; 13(11):6962-76. PubMed ID: 26610526
[TBL] [Abstract][Full Text] [Related]
48. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
[TBL] [Abstract][Full Text] [Related]
49. Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer.
Bousquet MS; Ma JJ; Ratnayake R; Havre PA; Yao J; Dang NH; Paul VJ; Carney TJ; Dang LH; Luesch H
ACS Chem Biol; 2016 May; 11(5):1322-31. PubMed ID: 26938486
[TBL] [Abstract][Full Text] [Related]
50. Silibinin inhibits expression of HIF-1alpha through suppression of protein translation in prostate cancer cells.
Jung HJ; Park JW; Lee JS; Lee SR; Jang BC; Suh SI; Suh MH; Baek WK
Biochem Biophys Res Commun; 2009 Dec; 390(1):71-6. PubMed ID: 19778521
[TBL] [Abstract][Full Text] [Related]
51. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions.
Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS
Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528
[TBL] [Abstract][Full Text] [Related]
52. Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1α pathway.
Shang FF; Wang JY; Xu Q; Deng H; Guo HY; Jin X; Li X; Shen QK; Quan ZS
Eur J Med Chem; 2021 Aug; 220():113474. PubMed ID: 33930802
[TBL] [Abstract][Full Text] [Related]
53. AK-1, a SIRT2 inhibitor, destabilizes HIF-1α and diminishes its transcriptional activity during hypoxia.
Lee SD; Kim W; Jeong JW; Park JW; Kim JE
Cancer Lett; 2016 Apr; 373(1):138-145. PubMed ID: 26808575
[TBL] [Abstract][Full Text] [Related]
54. Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221.
Creighton-Gutteridge M; Cardellina JH; Stephen AG; Rapisarda A; Uranchimeg B; Hite K; Denny WA; Shoemaker RH; Melillo G
Clin Cancer Res; 2007 Feb; 13(3):1010-8. PubMed ID: 17289897
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and evaluation of 3-(phenylethynyl)-1,1'-biphenyl-2-carboxylate derivatives as new HIF-1 inhibitors.
Wang S; Wang X; Shao Y; Shao K; Wang Y; Guo X; Dong H; Zhao W; Li Y; Li G
Bioorg Chem; 2021 Nov; 116():105298. PubMed ID: 34454298
[TBL] [Abstract][Full Text] [Related]
56. Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis.
Paradziej-Łukowicz J; Skwarska A; Peszyńska-Sularz G; Brillowska-Dąbrowska A; Konopa J
Cancer Biol Ther; 2011 Oct; 12(7):586-97. PubMed ID: 21775820
[TBL] [Abstract][Full Text] [Related]
57. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.
Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH
Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883
[TBL] [Abstract][Full Text] [Related]
58. Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha.
Koh MY; Spivak-Kroizman T; Venturini S; Welsh S; Williams RR; Kirkpatrick DL; Powis G
Mol Cancer Ther; 2008 Jan; 7(1):90-100. PubMed ID: 18202012
[TBL] [Abstract][Full Text] [Related]
59. Adamantaniline Derivatives Target ATP5B to Inhibit Translation of Hypoxia Inducible Factor-1α.
Li H; Liu Y; Xue Z; Zhang L; Ruan X; Yang J; Fan Z; Zhao H; Cao Y; Chen G; Xu Y; Zhou L
Adv Sci (Weinh); 2023 Sep; 10(25):e2301071. PubMed ID: 37401167
[TBL] [Abstract][Full Text] [Related]
60. Evodiamine represses hypoxia-induced inflammatory proteins expression and hypoxia-inducible factor 1alpha accumulation in RAW264.7.
Liu YN; Pan SL; Liao CH; Huang DY; Guh JH; Peng CY; Chang YL; Teng CM
Shock; 2009 Sep; 32(3):263-9. PubMed ID: 19106818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]